Baker Bros. Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Baker Bros. Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$781K	–	108
2019 Q3	$781K	Hold	50,000	–	–	0.01%	101
2019 Q2	$1.12M	Hold	50,000	–	–	0.01%	93
2019 Q1	$3.42M	Hold	50,000	–	–	0.02%	67
2018 Q4	$2.64M	Buy	+50,000	New	+$3.19M	0.02%	67
2017 Q1	–	Sell	-5,000	Closed	-$298K	–	133
2016 Q4	$298K	Hold	5,000	–	–	﹤0.01%	129
2016 Q3	$364K	Hold	5,000	–	–	﹤0.01%	130
2016 Q2	$398K	Hold	5,000	–	–	﹤0.01%	129
2016 Q1	$1.35M	Hold	5,000	–	–	0.01%	111
2015 Q4	$3.01M	Hold	5,000	–	–	0.02%	92
2015 Q3	$4.1M	Buy	+5,000	New	+$5.64M	0.04%	82

Other funds holding SRRA

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

Baker Bros. Advisors's SRRA Position: Q4 2019 in Review

Baker Bros. Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2019, closing a stake of 50,000 shares — an estimated $781K sold.

Baker Bros. Advisors first reported a position in SRRA in Q3 2015 and held it in 10 quarters. The position peaked at $4.1M in Q3 2015. 29 funds tracked by Wall St. Rank hold SRRA as of Q4 2019.

Baker Bros. Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Baker Bros. Advisors sold 50,000 Sierra Oncology, Inc. Common Stock shares in Q4 2019, an estimated $781K.
Baker Bros. Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 10 quarters.
Baker Bros. Advisors's Sierra Oncology, Inc. Common Stock position peaked at $4.1M in Q3 2015.
29 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2019.

Based on Baker Bros. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.